Show notes
Llewellyn King discusses the hurdles for innovative drug development at small biotech companies with Linda Marbán, CEO of Capricor Therapeutics and Angelos Stergiou, MD, President and CEO, STELLAS Life Sciences Group, Inc.
Llewellyn King discusses the hurdles for innovative drug development at small biotech companies with Linda Marbán, CEO of Capricor Therapeutics and Angelos Stergiou, MD, President and CEO, STELLAS Life Sciences Group, Inc.